Datasheet: Live Single Cell Functional Analysis with Beacon Discoveryâ„¢
Access Resource

Bruker Cellular Analysis / Cell Line Development
Cellular Analysis Blog

Explore Cell Line Development Articles

Latest
Population Dynamics Workflow Overview
Introducing the Optoâ„¢ CLD with Population Dynamics Kit for Improved Stability Prediction

Since its introduction in 2017, the Beacon® platform has transformed how cell line development (CLD) teams reduce campaign risk and accelerate timelines. Today, over a third of CLD teams worldwide use the Beacon platform to streamline workflows and improve decision-making earlier in the process [1]. One of the greatest challenges in CLD is identifying clones […]

webinar-recap-pushing-the-boundaries-in-cell-ine-development
Pushing the Boundaries in Cell Line Development: Webinar Recap

This past February and March, Bruker Cellular Analysis, in partnership with BioProcess International, hosted a dynamic two-part webinar series – Pushing the Boundaries in Cell Line Development – spotlighting the capabilities of the Beacon® Optofluidic platform for cell line development (CLD). Now available on demand, these sessions offer a front-row view into how cutting-edge technology […]

accelerating-the-cell-line-development-timeline-beacon-platform-spotlight-reagents
Accelerating the Cell Line Development Timeline: How to Deliver Lead Clones in Six Weeks

In the complex world of biologics manufacturing, cell line development (CLD) plays a crucial role in bringing new biologic therapies to patients.

blog-Revolutionizing-Bispecific-Antibody-Production
Revolutionizing Bispecific Antibody Production Using the Beacon® Platform

Bispecific Antibodies: An Emerging Therapeutic Paradigm Bispecific antibodies (bsAbs) are rapidly gaining momentum in the pharmaceutical industry as a revolutionary class of therapeutics. While monoclonal antibodies (mAbs) have dominated the biologics landscape for decades, bsAbs offer unique therapeutic mechanisms by targeting two different antigens simultaneously. This capability enables novel treatment strategies, particularly in cancer immunotherapy, […]

Beacon® and Chip
Efficiency with Excellence: Expedite Cell Line Development Timelines with the Beacon® Platform’s Selective Cell Cloning

In the biopharmaceutical industry, where lengthy antibody therapeutic development timelines can delay critical treatments for patients in need, accelerating cell line development (CLD) has never been more crucial. The Beacon® optofluidic system by Bruker Cellular Analysis has emerged as a revolutionary platform, offering unparalleled efficiency in CLD processes by enabling a suite of powerful assays […]

Unlock the Phenome